BS EN 50527-2-2:2018

What is BS EN 50527‑2‑2- Specific assessment for workers with cardioverter defibrillators (ICDs) about?

BS EN 50527 discusses the procedure for the assessment of the exposure to electromagnetic fields of workers. BS EN 50527‑2‑2 is a European standard that provides for the specific assessment for workers with cardioverter defibrillators (ICDs) to ensure protection to workers from electromagnetic hazards.

BS EN 50527‑2‑2 is the second subpart of the second part of a multi-part series that provides the procedure for the specific assessment required in EN 50527-1:2016, Annex A, for workers with implanted cardioverter defibrillators (ICDs) and Cardiac Resynchronization Therapy devices with associated defibrillation functions (CRT-D). Only devices of this type equipped with leads implanted transvenously are considered. BS EN 50527‑2‑2 offers different approaches for doing the risk assessment.

The purpose of the specific assessment is to determine the risk for workers with implanted ICDs and CRT-Ds arising from exposure to electromagnetic fields (EMF) at the workplace. The assessment includes the likelihood of clinically significant effects and takes account of both transient and long-term exposure within specific areas of the workplace.

Note: BS EN 50527‑2‑2 does not address risks from contact currents.

Who is BS EN 50527‑2‑2Specific assessment for workers with cardioverter defibrillators (ICDs) for?

BS EN 50527‑2‑2 on the  specific assessment for workers with cardioverter defibrillators (ICDs) is relevant to:

• Cardioverter defibrillators manufacturers
• AIMD-Employee and his responsible physician
• Cardioverter defibrillators test personnel
• Occupational health and safety departments
• Risk assessment departments

Why should you use BS EN 50527‑2‑2-Specific assessment for workers with cardioverter defibrillators (ICDs)?

An implantable cardioverter-defibrillator or automated implantable cardioverter-defibrillator is a device implantable inside the body, able to perform defibrillation depending on the type, cardioversion, and pacing of the heart.

BS EN 50527‑2‑2 provides you with assessment methods, specific assessment, equipment consideration, the basic procedure for the device in vitro testing, clinical investigation methods, and much more.

The methods and procedures provided by BS EN 50527‑2‑2 assist in the assessment of the exposure to electromagnetic fields of workers bearing active implantable medical devices to reduce the risk of EMF exposure on workers.

By adopting BS EN 50527‑2‑2 the user can identify health and safety hazards and evaluate the risks present within the workplace to create a safe and healthy workplace for workers with cardioverter defibrillators (ICDs).